Table A-3. ERIC search strategies (ProQuest interface) Search terms Search results #1 SU.EXACT.EXPLODE("Autism") OR SU.EXACT("Pervasive Developmental Disorders") OR SU.EXACT.EXPLODE("Asperger Syndrome") 9380 #2 SU.EXACT.EXPLODE("Therapy") OR SU.EXACT.EXPLODE("Intervention") OR SU.EXACT.EXPLODE("Outcomes of Treatment") OR SU.EXACT.EXPLODE("Special Education") OR SU.EXACT.EXPLODE("Dietetics") OR SU.EXACT.EXPLODE("Nutrition") OR SU.EXACT.EXPLODE("Adapted Physical Education") OR SU.EXACT.EXPLODE("Therapeutic Environment") OR SU.EXACT.EXPLODE("Food") 80298 #3 #1 and #2 and LA(English), limited to peer reviewed journals, 2000 to present 1782** Key: DE subject descriptor, KW keyword A-2 Appendix B. Screening and Quality Assessment Forms Abstract Review Form REF ID: Reviewer Initials: 1. Addresses intervention approach and outcomes for young children (0-12 years) with ASD or at risk for ASD. Yes No Cannot Determine 2. Original research (includes primary research studies and systematic reviews and meta-analyses) Yes No Cannot Determine 3. Includes individuals with ASD in target age range (0-12 years). Yes No Cannot Determine 4. Addresses one of the following: • treatment modality for ASD intended to modify core symptoms of ASD in individual diagnosed/at risk • short or long term outcomes of treatment intended to modify core symptoms/co- morbidities of ASD in individual diagnosed/at risk; outcomes include parent or child QOL • modifiers of treatment outcomes in young children with ASD • generalization of treatment outcomes to another person/context • drivers of treatment outcomes • harms/adverse effects associated with treatment intended to modify core symptoms of ASD in individual diagnosed/at risk Yes No Cannot Determine 5. Eligible study size (at least 10 total participants in target population) Yes No Cannot Determine 6. If excluded, retain for review of references or background/contextual questions (screening or treatment resources, stability of diagnosis)? Yes No Cannot Determine Comments: B-1 Full Text Review Form REFID: Reviewer Initials: 1. Does the study include participants ages 2 - 12 (mean age+SD less than or equal to 12 yrs 11 mo) diagnosed with ASD or 0-2 at risk for ASD diagnosis? Yes No 2. Is the study original research (includes systematic review or meta-analysis)? Yes No 3. Does the study include at least 10 individuals with ASD in the target age range? Yes No 4. Does the study provide data related to at least one of the following? • Effects of intervention on core ASD symptoms OR commonly associated symptoms (e.g., motor, sensory, medical, mood/anxiety, irritability, IQ/cognition, and hyperactivity) • Modifers of treatment outcomes • Generalizability of intervention effects to other contexts (e.g., people, places, materials) • Intervention components that drive outcomes • Harms of intervention • Child or caregiver quality of life Yes No 5. If excluded, retain this paper for background or review of references? Yes No Comments: B-2 Quality/Risk of Bias Rating Form REFID:____________ REVIEWER:_____________ Question Study Design Did the study employ a group design? Yes No Were the groups randomly assigned? Yes No Was there an appropriate comparison group? Yes No or NR If an RCT, was randomization done correctly? Yes No NR NA (non-RCT) Participant Ascertainment/Inclusion Was a valid diagnostic approach for ASD used within the study, or were referred participants diagnosed using a valid approach? A. clinical DSM-IV-based diagnosis +